Latest news
Spotlight on Best disease
Posted: Thursday 4 February 2021
February’s condition-specific Virtual Clinic will shine the spotlight on Best disease – a rare inherited form of macular disease.
Find out more
'What better way to start 2021 than by opening my front door and climbing Mount Everest'
Posted: Thursday 4 February 2021
A former Macular Society regional manager has proven you do not need to leave home to take on a big challenge in 2021, after scaling the height of Mount Everest without stepping outside.
Find out more
What role does genetics play in AMD?
Posted: Tuesday 2 February 2021
It is known that a very significant proportion of the risk of developing age-related macular degeneration (AMD) is in our genes.
Find out more
New survey for patients with diabetic eye disease
Posted: Thursday 28 January 2021
The Macular Society is calling for patients with diabetic macular oedema (DMO) to take part in a new survey, to help improve treatment and quality of life for patients.
Find out more
New research suggests air pollution could increase the risk of developing AMD
Posted: Tuesday 26 January 2021
Air pollution is linked to a heightened risk of developing age-related macular degeneration (AMD), according to a new study.
Find out more
Help improve home testing experiences for visually impaired people
Posted: Tuesday 19 January 2021
We are supporting NHS Test and Trace to conduct research into the experience and accessibility of getting a home test for the coronavirus.
Find out more
Webinar to explore the latest in research and treatment for DMO
Posted: Wednesday 13 January 2021
The first condition of our condition-specific Virtual Clinic of 2021 will take place later this month, focusing on diabetic macular oedema (DMO)
Find out more
Medical research at risk
Posted: Thursday 7 January 2021
The progress of macular research is under threat as the coronavirus could leave a huge hole in medical research funding.
Find out more
No interruption to medicine supplies for macular patients after Brexit
Posted: Thursday 7 January 2021
Pharmaceutical companies have provided reassurances that there will be no interruption to medicine supplies for patients with macular disease, after the transition period ended on 31 December.
Find out more
What do the latest coronavirus restrictions mean for eye care services?
Posted: Thursday 7 January 2021
As new lockdowns are announced in England and Scotland this week, and there are restrictions already in place in Wales and Northern Ireland, we ask what this means for eye care.
Find out more
Tricky conversations
Posted: Thursday 7 January 2021
Conversations about macular disease can be hard to start, and hard to hear. Find out how we’re working with the Optical Consumer Complaints Services (OCCS) to make them easier and more productive.
Find out more
What's the latest in research and how can you get involved in clinical trials?
Posted: Wednesday 6 January 2021
Last year we launched our Virtual Clinics – a series of webinars bringing you closer to the experts.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter